You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

EVENTS

Leading medical-scientific event on Hemophilia held in Trieste, Italy

Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight

read more 

EVENTS

Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy

A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN

read more 

PLASMA & BIOTHERAPIES

First patient enrolled and treated in Kedrion’s CARES10 clinical study

Phase 3 study to assess efficacy, safety and pharmacokinetics of a 10% IVIg in the treatment of adult PID patients

read more 
  1. PLASMA & BIOTHERAPIES - 14-04-2014

    Kedrion collection centers first to be certified in Hungary

    Plazmaferezis Állomás Kft achieves international PPTA certification

    read more 
  2. EVENTS - 01-04-2014

    Kedrion supports World Hemophilia Day

    The goal is to improve access to treatments for people suffering from hemophilia and other hemorrhagic conditions

    read more 
  3. EVENTS - 31-03-2014

    Award in the US for efforts to support hemophilia patients communities

    Kedrion’s Vice-President of North American Commercial Operations is “Man of the Year” for the Hemophilia Association of New Jersey

    read more 
  4. EVENTS - 11-02-2014

    Conference in Colombia: Professor Mannucci on the future of hemophilia

    The event, open to industry experts, patients’ associations and the scientific community, took place in Medellín on February 12th, 2014

    read more 

Pages

For more information please contact: pressoffice@kedrion.com